The impact of the Covid-19-Pandemic on patients in DMP diabetes
- Conditions
- E11Type 2 diabetes mellitus
- Registration Number
- DRKS00025333
- Lead Sponsor
- Zentrum für AllgemeinmedizinMedizinische Fakultät der Universität des Saarlandes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
legal age, legal competence
- patients with type 2 diabetes that take part in the DMP
- Enlightenment and presence of a written consent
Exclusion Criteria
- missing consent
- patents that are suffering from diabetes, but are not enrolled in the DMP
- Patients that sickened from Covid-19
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Routinely, blood samples were extracted framed in the DMP between January 2020 and September 2020 and the HbA1c value was defined. <br>
- Secondary Outcome Measures
Name Time Method The definition of cholesterol, LDL-Cholesterol, HDL-Cholesterol and Trigyceride took place routinely with the extraction of blood samples between January 2020 and September 2020. <br>Additionally, weight and blood pressure were defined.